摘要
目的:探讨普米克令舒雾化吸入对支气管哮喘患儿肺功能的影响。方法:将84例支气管哮喘患儿用普米克令舒雾化吸入,2次/d,共治疗14d。观察治疗前后支气管哮喘患儿肺功能的变化。结果:治疗后患儿的肺功能各项指标均有明显好转,以FEV1和FEF50%更为显著。经统计学分析治疗前后差异有统计学意义(P<0.05)。结论:普米克令舒雾化吸入治疗支气管哮喘患儿的疗效显著,可以作为主要措施在临床中推广应用。
Objective Toinvestigate the clinical effects of the pulmicort respules （ budsonide nebulising suspension） inhalation on children with bronchial asthma. Method For 84 cases admitted to hospital with bronchial asthma, were treated with pulmicort respules inhalation （bid for 14 days）. The clinical effects were evaluated by pulmonary function. Results The children treated with inhaled pulmicort respules showed a rapid improvement in respiratory symptoms （such as wheezing, cough） and airway obstruction, especially FEV1 and FEF50%. The pulmonary function also improved obviously after treatment compared with that of before（ P 〈 0. 05 ）. Conclusion The clinical symptoms of bronchiolitis can be controlled and the pulmonary function can be promoted with the use of the pulmicort respules inhalation, which is convenient and without many side - effects. It can be one of the principal drugs in the treatment of children with bronchial asthma.
出处
《吉林医学》
CAS
2009年第5期412-413,共2页
Jilin Medical Journal
